Buy & Build: where next?

European private equity activity has gone from strength to strength in recent years. While global economic disruption has ramped up, the sector remains robust; private equity can bring a clear vision, strategy and focus to strong businesses that have not yet been optimised for growth. So, how can investors continue to create value?

Technology bolsters the pharma industry; creates M&A opportunities

Technology is playing an increasingly important role in the life sciences and pharmaceutical industry, leading to an increase in M&A

The changing face of B2B sales

The B2B sales function of today must adapt to the evolving expectations of its customers. In a recent webinar, CIL’s Jon Whiteman and Axel Leichum were joined by Allister Frost, former head of digital marketing strategy at Microsoft, to discuss the changing face of B2B sales.

VCDD: Improving process, predictability and price

A recent CIL survey of investment banks found that the use of vendor commercial due diligence has increased significantly in the last ten years as vendors and buyers alike recognise its value in transaction processes. In this presentation, we outline the key benefits VCDD brings to the sales process.